Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/6/24 21:47 | 2/5/24 | IMGN | Health | Drug | Pharmaceutical Preparations | Coen Stacy Ann | MA | O | SVP,Chie | 5 | S.dm | -4,858 | 16.10 | 0 | -302 | 73 | D | |||||||||||||||
2/6/24 21:43 | 2/5/24 | IMGN | Health | Drug | Pharmaceutical Preparations | Wingrove Theresa | MA | O | SVP of R | 8 | S.dm | -22,938 | 21.67 | 0 | -1,059 | 21 | D | |||||||||||||||
2/6/24 21:42 | 2/5/24 | IMGN | Health | Drug | Pharmaceutical Preparations | Enyedy Mark J | MA | DO | CEO | 2 | S.dm | -51,734 | 17.09 | 0 | -3,028 | 584 | D | |||||||||||||||
2/6/24 21:41 | 2/5/24 | IMGN | Health | Drug | Pharmaceutical Preparations | Lentini Renee | MA | O | VP,PRIN | 4 | S.d | -6,231 | 16.53 | 0 | -377 | 74 | D | |||||||||||||||
12/5/23 21:06 | 11/30/23 | IMGN | Health | Drug | Pharmaceutical Preparations | Peterson Kristine | MA | D | 1 | S.d | -578 | 28.90 | 0 | -20 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |